← Insider buys
EXEL

Exelixis, Inc. · Healthcare

Director Stelios Papadopoulos sold $558K of Exelixis, Inc.

Sold$557,813
$21.25Price
26,250Shares
−2%Stake

What EXEL did after the filing

Prices for EXEL after this filing aren't in yet.

Traded Thu, Feb 21. Filed Fri, Feb 22, 7:35 PM ET, after the close. Not investment advice.